Abstract
Purpose
To investigate the relationship among the International Index of Erectile Function (IIEF), International Prostate Symptom Score (IPSS), and Aging Males’ Symptoms (AMS) scale scores in various age groups of males.
Patients and methods
A total of 307 male patients enrolled in the study. Mean age was 52.3 (range 21–77) years. Group 1 consisted of 51 (≤39 years), Group 2 consisted of 160 (40–59 years), and Group 3 consisted of 96 (≥60 years) patients. First five and 15th questions of the IIEF, IPSS, and AMS scale were replied by all the patients. The patients were assessed based on the IIEF for erectile dysfunction (ED), IPSS for lower urinary tract symptoms (LUTS), and AMS scale for Symptomatic Late-Onset Hypogonadism (SLOH).
Results
ED, LUTS, and SLOH symptoms were detected in 236 (76.8%), 162 (52.8%), and 184 (59.9%) patients. Except for total AMS scores, IIEF and IPSS scores were significantly different among the groups (p AMS = 0.320, p IIEF = 0.000, p IPSS = 0.000). In the comparisons of the IIEF scores between the each group, significant differences were observed (p Group1–Group2 = 0.000, p Group1–Group3 = 0.000, p Group2–Group3 = 0.000). Nevertheless, IPSS score was significantly lower in the patients with age ≤39 years than the other age groups (p = 0.000).
Conclusions
In the present study, ED ratio and LUTS severity significantly increased in older men. We did not find significant relationship between aging and SLOH symptoms. In the light of our results, LUTS seems to be an important risk factor on erectile function.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Diczfalusy E (1998) An aging humankind:is our future behind us? Aging Male 1:8–14
Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL Mebust WK, Cockett AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148:1549–1557
Hafez B, Hafez ES (2004) Andropause:endocrinology, erectile dysfunction and prostate pathophysiology. Arch Androl 50:45–68
Morales A, Heaton JPI, Carson CC III (2000) Andropause:a misnomer for a true clinical entity. J Urol 163:705–712
Morales A, Lunenfeld B (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 5:74–86
Heinemann LAJ, Zimmermann T, Vermuelen A, Thiel C (1999) A new aging males’ symptoms (AMS) rating scale. Aging Male 2:105–114
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF):a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–830
Moore C, Huebler D, Zimmermann T, Heinemann LAJ, Saad F, Thai DM (2004) The aging males’ symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 46:80–87
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates:results of the Massachusetts Male Aging Study. J Urol 151:54–61
Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025–1030
Shabsigh R, Fishman IJ, Schum C, Dunn JK (1991) Cigarette smoking and other risk factors in vasculogenic impotence. Urology 38:227–231
Kaufman JM, Vermeulen A (1997) Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 11:289–309
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total, free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 86:724–731
Vermeulen A (2000) Andropause. Maturitas 34:5–15
Buena F, Swerdloff RS, Steiner BS, Lutchmansingh P, Peterson MA, Pandian MR, Galmarini M, Bhasin S (1993) Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 59:1118–1123
Walsh PC (1992) Benign prostate hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s Urology, 6th edn. Saunders, Philadelphia WB,. pp 1007–1027
Moncada I (2003) LUTS:a risk factor for sexual dysfunction in the BPH patient. Eur Urol suppl 2:3–8
Rosen RC, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary M, Puppo P, Robertson C, Giuliano F (2003) Lower urinary tract symptoms and male sexual dysfunction:the Multi-National Survey of the Ageing Male (MSAM-7). Eur Urol 44:637–649
Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH (2003) Lower urinary tract symptoms and erectile dysfunction:co-morbidity or typical “aging male” symptoms? results of the “Cologne Male Survey”. Eur Urol 44:588–594
Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeu P, McCready D, Perry HM III (2000) Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49:1239–1242
T’Sjoen G, Feyen E, De Kuyper P, Comhaire F, Kaufman JM (2003) Self-referred patients in an aging male clinic:much more than androgen deficiency alone. Aging Male 6:157–165
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atan, A., Basar, M.M., Tuncel, A. et al. Is there a relationship among age, international index of erectile function, international prostate symptom score, and aging males’ symptoms score?. Int Urol Nephrol 39, 215–222 (2007). https://doi.org/10.1007/s11255-006-9153-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-006-9153-y